Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

News Industry News

Cordis Corporation Expands Crossing Portfolio for the Treatment of Chronic Total Occlusions

June 08, 2015

News Industry News

Abiomed Impella 2.5 Receives FDA Approval for Elective and Urgent High Risk Percutaneous Coronary Intervention (PCI) Procedures

March 23, 2015

News Industry News

Medtronic Drug-Coated Balloon for Peripheral Artery Disease Also Benefits Patients with Diabetes in Landmark Study

November 03, 2014

News Industry News

Randomized Study Demonstrates the Superiority of Laser Atherectomy for Treatment of In-Stent Restenosis in Patients with Femoropopliteal Peripheral Artery Disease

September 16, 2014

News Industry News

Randomized Trial of Intravascular Ultrasound-Guided Intervention Demonstrates Improved Outcomes for Patients with Chronic Total Coronary Artery Occlusion

September 14, 2014

News Industry News

Study Finds Drug-Eluting Stents Exhibit Some Benefits Over Bare-Metal Stents In Patients Over 80, Though Both Demonstrate Clinical Benefit

October 26, 2012

News Industry News

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

October 18, 2012

News Industry News

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

May 15, 2012

News Industry News

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

March 06, 2012

News Industry News

Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy

November 07, 2011

News Industry News

Two-Year Follow-Up Data Show Outstanding Clinical Outcomes and Safety for OrbusNeich's GenousTM Stent in Patients at High Risk for Restenosis

August 16, 2011

News Industry News

Positive Long-term Safety and Efficacy Demonstrated for OrbusNeich's GenousTM Stent in Large, Unselected Patient Population with Mostly Complex Lesions and Estimated High Risk for Restenosis

March 28, 2011

News Industry News

Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions

February 14, 2011

Advertisement

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

Cordis Corporation Expands Crossing Portfolio for the Treatment of Chronic Total Occlusions

Abiomed Impella 2.5 Receives FDA Approval for Elective and Urgent High Risk Percutaneous Coronary Intervention (PCI) Procedures

Medtronic Drug-Coated Balloon for Peripheral Artery Disease Also Benefits Patients with Diabetes in Landmark Study

Randomized Study Demonstrates the Superiority of Laser Atherectomy for Treatment of In-Stent Restenosis in Patients with Femoropopliteal Peripheral Artery Disease

Randomized Trial of Intravascular Ultrasound-Guided Intervention Demonstrates Improved Outcomes for Patients with Chronic Total Coronary Artery Occlusion

Study Finds Drug-Eluting Stents Exhibit Some Benefits Over Bare-Metal Stents In Patients Over 80, Though Both Demonstrate Clinical Benefit

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy

Two-Year Follow-Up Data Show Outstanding Clinical Outcomes and Safety for OrbusNeich's GenousTM Stent in Patients at High Risk for Restenosis

Positive Long-term Safety and Efficacy Demonstrated for OrbusNeich's GenousTM Stent in Large, Unselected Patient Population with Mostly Complex Lesions and Estimated High Risk for Restenosis

Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content